Canada recommends Verkazia reimbursement

The Canadian Drug Expert Committee has issued a reimbursement recommendation for Verkazia eye drops, a treatment for severe vernal keratoconjunctivitis, according to a press release.

Verkazia (cyclosporine 0.1% topical ophthalmic emulsion, Santen) is indicated for children from the age of 4 years through adolescence.

The final decision on public reimbursement will be made by provincial jurisdictions, the release said.

The Canadian Drug Expert Committee has issued a reimbursement recommendation for Verkazia eye drops, a treatment for severe vernal keratoconjunctivitis, according to a press release.

Verkazia (cyclosporine 0.1% topical ophthalmic emulsion, Santen) is indicated for children from the age of 4 years through adolescence.

The final decision on public reimbursement will be made by provincial jurisdictions, the release said.